Get the Stockscreener App
1.165
0.42%
-0.015
Oncolytics Biotech Inc stock is traded at $1.165, with a volume of 502.38K.
It is down -0.42% in the last 24 hours and down -7.48% over the past month.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.
See More
Previous Close:
$1.18
Open:
$1.18
24h Volume:
502.38K
Relative Volume:
0.50
Market Cap:
$116.92M
Revenue:
-
Net Income/Loss:
$-20.31M
P/E Ratio:
-4.4045
EPS:
-0.2645
Net Cash Flow:
$-21.07M
1W Performance:
+0.43%
1M Performance:
-7.48%
6M Performance:
+107.38%
1Y Performance:
-3.69%
1-Day Range:
$1.16
$1.21
1-Week Range:
$1.095
$1.21
52-Week Range:
$0.3258
$1.51
Oncolytics Biotech Inc Stock (ONCY) Company Profile
Compare ONCY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ONCY
Oncolytics Biotech Inc
|
1.165 | 112.38M | 0 | -20.31M | -21.07M | -0.2645 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.23 | 109.29B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.36 | 62.13B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
574.27 | 61.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
816.97 | 51.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
310.01 | 34.68B | 4.56B | -176.77M | 225.30M | -1.7177 |
Oncolytics Biotech Inc Stock (ONCY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-13-25 | Initiated | Lake Street | Buy |
| Oct-06-22 | Initiated | Maxim Group | Buy |
| Feb-17-21 | Initiated | H.C. Wainwright | Buy |
Oncolytics Biotech Inc Stock (ONCY) Latest News
Is Oncolytics Biotech Inc. stock overvalued by current metricsJuly 2025 Rallies & Stepwise Entry/Exit Trade Alerts - newser.com
Backtesting results for Oncolytics Biotech Inc. trading strategiesWeekly Trade Review & AI Forecast Swing Trade Picks - newser.com
Oncolytic Virus Therapy Market To Witness Substantial Growth, - openPR.com
Published on: 2025-10-23 03:55:05 - newser.com
Can you recover from losses in Oncolytics Biotech Inc.Fed Meeting & Real-Time Buy Signal Alerts - newser.com
What dividend safety score for Oncolytics Biotech Inc. stockAnalyst Downgrade & Accurate Buy Signal Alerts - newser.com
Identifying reversal signals in Oncolytics Biotech Inc.2025 Dividend Review & Consistent Return Strategy Ideas - newser.com
Will breakout in Oncolytics Biotech Inc. lead to full recoveryWeekly Trade Analysis & High Accuracy Investment Entry Signals - newser.com
How to Take Advantage of moves in (ONC) (ONC:CA) - news.stocktradersdaily.com
Why analysts remain bullish on Oncolytics Biotech Inc. stockTrade Analysis Report & Daily Volume Surge Signals - newser.com
Is Oncolytics Biotech Inc. forming a reversal patternQuarterly Trade Report & Precise Buy Zone Tips - newser.com
Will earnings trigger a reversal in Oncolytics Biotech Inc.Dollar Strength & AI Enhanced Execution Alerts - newser.com
Understanding Oncolytics Biotech Inc.’s price movementJuly 2025 Rallies & Stepwise Entry/Exit Trade Alerts - newser.com
Is Oncolytics Biotech Inc. reversing from oversold territoryEarnings Overview Summary & Community Verified Swing Trade Signals - newser.com
Comparing Oncolytics Biotech Inc. in custom built stock radars2025 Price Targets & Reliable Breakout Stock Forecasts - newser.com
Will Oncolytics Biotech Inc. outperform the market2025 Bull vs Bear & Consistent Return Investment Signals - newser.com
Stocks in play: Oncolytics Biotech Inc - Barchart.com
Oncolytics Biotech Plans Jurisdiction Shift to Nevada - TipRanks
Oncolytics Biotech (ONCY) Secures $50 Million ATM Financing Deal - GuruFocus
Oncolytics Biotech files circular/prospectus for special meeting of shareholders to change jurisdiction of incorporation to Nevada - MarketScreener
Oncolytics Biotech® Files Circular/Prospectus for Special Meeting of Shareholders To Change Jurisdiction of Incorporation to Nevada - PR Newswire
Is Oncolytics Biotech Inc. stock positioned for long term growthJuly 2025 EndofMonth & Reliable Price Breakout Alerts - newser.com
Is Oncolytics Biotech Inc a good long term investmentEconomic Indicators Overview & Maximize Returns With Insights - earlytimes.in
Candlestick signals on Oncolytics Biotech Inc. stock todayPortfolio Performance Summary & Weekly Market Pulse Alerts - newser.com
Oncolytics Biotech Inc. stock trendline breakdown2025 Technical Overview & Real-Time Stock Movement Alerts - newser.com
Using RSI to spot recovery in Oncolytics Biotech Inc.July 2025 Setups & Technical Pattern Based Buy Signals - newser.com
How Oncolytics Biotech Inc. stock trades before earningsJuly 2025 Sector Moves & Precise Trade Entry Recommendations - nchmf.gov.vn
Oncolytics Biotech files for common stock offering of $50 millionSEC filing - MarketScreener
Oncolytics Biotech Inc Stock Analysis and ForecastHigh Dividend Yield Stocks & Budget Friendly Growth - earlytimes.in
ONCY seeks approval to redomicile to Nevada and adopt 2025 plan - Stock Titan
Relative strength of Oncolytics Biotech Inc. in sector analysisWeekly Risk Report & Weekly Stock Performance Updates - newser.com
Published on: 2025-10-13 09:59:15 - newser.com
Published on: 2025-10-13 08:31:55 - newser.com
Published on: 2025-10-13 07:15:35 - newser.com
Oncolytics Biotech Inc. (NASDAQ:ONCY) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Oncolytics Biotech Inc Stock (ONCY) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.24%
1.76%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):